Generic prescribing in India: a stumbling block


  • Sukhpreet Kaur Department of Pharmacology, Dasmesh Institute of Research and Dental Sciences, Faridkot, Punjab, India



Barriers, Cost saving, Dental practitioners, Generic prescribing, Negative perception


In India, there is 62% out-of-pocket health expenditure per capita and only 15% are covered by health insurance. The use of generics can save a lot of money which can be used for other health issues. But lack of knowledge about cost effectiveness of generic medicines among various health-care professionals had led to a low rate of generic medicine prescription in India. This review aims to identify the barriers in adoption of generic prescribing in clinical practice in India. A systematic literature review was conducted using various healthcare databases such as PubMed and google scholar. The literature search using various combination of keywords retrieved 2360 articles. After excluding duplicates, articles in languages other than English and based on relevance to subject only 15 articles were selected. The barriers to generic prescribing identified from reported literature can be broadly classified based on stakeholders of healthcare setting such as physicians, patients, pharmacist and government policies. The major barriers to generic prescribing identified were negative perception of various stakeholders, lack of awareness of regulatory standards, maturity of health care system, vulnerability of patients, lack of standard guidelines in brand substitution, incentives and influence of drug advertisements. In Indian set up, studies on impact evaluation of generic prescription, emphasizing the quality and cost saving by their use in clinical practice should be conducted. This evidence will help to build the confidence of various stakeholders towards implementing generic prescribing in clinical practice.

Author Biography

Sukhpreet Kaur, Department of Pharmacology, Dasmesh Institute of Research and Dental Sciences, Faridkot, Punjab, India

Assistant Professor

Department of Pharmacology


Jamshed SQ, Hassali MA, Ibrahim MI, Babar ZU. Knowledge attitude and perception of dispensing doctors regarding generic medicines in Karachi, Pakistan: a qualitative study. J Pak Med Assoc. 2011;61:80-3.

Bakthavathsalam G. Generic drugs: cost effective alternative to branded drug. Health Administrator. 2006;19:16-9.

Jamshed SQ, Ibrahim MIM, Hassali MA, Masood I, Low BY, Shafie AA, et al. Perception and attitude of general practitioners regarding generic medicines in Karachi, Pakistan: a questionnaire based study. Southern Med Rev. 2012;5(1):22-30.

Dylst P, Vulto A, Simoens S. How can pharmacist remuneration systems in Europe contribute to generic medicine dispensing? Pharm Pract. 2012;10(1):3-8.

Singhal AK, Solanki MN, Dave DJ. Perceptions and practice of use of generic medicines by intern doctors at a tertiary care teaching hospital -a cross sectional study”. Saudi J Med Pharm Sci. 2019;5(11):972-8.

Live M. Medicine costs form bulk of out-of-pocket health expenses: NSSO. Available at: Accessed on 15th May 2020.

Thawani V, Mani A, Upmanyu N. Why the Jan Aushadhi scheme has lost its steam in India?. J Pharmacol Pharmacother. 2017;8(3):134-6.

StayHappyPharmacy. The State of Generic Medi-cines in India. Available at:, genericnameequivalentsbeingsold. Accessed on 18th June 2020.

Scroll. In. Indian government may ask doctors to prescribe medicines under generic names. Is it practical? Available at: Accessed on 18th June 2020.

Kumar R, Hassali MA, Saleem F, Alrasheedy AA, Kaur N, Wong ZY, et al. Knowledge and perceptions of physicians from private medical centers towards generic medicines: a nationwide survey from Malaysia. J Pharma Policy Pract. 2015;8:11.

Catic T, Avdagic L, Martinovic I. Knowledge and attitudes of physicians and pharmacists towards the use of generic medicines in Bosnia and Herzegovina. Med Glas (Zenica). 2017;14(1):25-32.

Choudhary NK, Denberg TD, Qaseem A. Improving Adherence to therapy and clinical outcomes while containing costs: opportunities from the greater use of generic medications: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med. 2016;164:41-9.

Toverud EL, Hartman K, Hakonsen H. A systematic review of physicians’ and pharmacists’ perspectives in generic drug use: what are the global challenges?. Appl Health Econ Health Policy. 2015;13:S35-45.

O’Leary A, Usher C, Lynch M, Hall M, Hemeryk L, Spillane S et al. Generic medicines and generic substitution: contrasting perspectives of stakeholders in Ireland. BMC Res Notes. 2015;8:790.

Decollogny A, Eggli Y, Halfon P, Lufkin TM. Determinants of generic drug substitution in Switzerland. BMC Health Service Res. 2011;11:17.

Aivalli PK, Elias MA, Pati MK et al. Perceptions of the quality of generic medicines: implications for trust in public services within the local health system in Tumkur, India. BMJ Glob Health. 2018; 2:e00064.

Patel A, Gauld R, Norris P, Rades T. Quality of generic medicines in South Africa: perceptions versus reality-a qualitative study. BMC Health Services Res. 2012;12:297.

Gebrosillassie BM, Betachew SA, Tefera YG, Abebe TB, Mekuria AB, Haile KT et al. Evaluating patients’, physicians’ and pharmacy professionals’ perception and concern regarding generic medicines in Gondar town, northwest Ethiopia: A multi-stakeholder, cross-sectional survey. PloS One. 2018;13(11): e0204146.

Nguyen TA, Hassali MA, McLachlan A. Generic medicines policies in the Asia Pacific region: ways forward”, WHO South-East Asia Journal of Public Health. 2013;2(1):72-4.

Dunne SS, Shannon B, Cullen W, Dunnne CP. Beliefs, perceptions and behaviors of GPs towards generic medicines. Family Pract. 2014;31(4):467-4.

Hassali MA, Shafie AA, Jamshed S, Ibrahim MI, Awaisu A. Consumers’ views on generic medicines: a review of literature. Int J Pharm Pract. 2009;17:79-88.

Hassali MA, Alrasheedy AA, McLachlan A, Ngugen TA, Al-Tamimi SK, Izham M, et al. The experiences of implementing generic medicine policy in eight countries: a review and recommendations for a successful promotion of generic medicine use. Saudi Pharmaceutical Journal. 2014;22:491-503.

Kaplan WA, Ritz LS, Vitello M, Wirtz VL. Policies to promote use of generics medicines in low and middle income countries: a review of published literature 2000-2010. Health Policy. 2012;106(3):211-24.

Moe-Byrne T, Chambers D, Harden M, McDald C. Behaviour change interventions to promote prescribing of generic drugs: a rapid evidence synthesis and systematic review. BMJ Open. 2014;4(5):e004623.

Cantillon P, Jones R. Does continuing medical education in general practice make a difference?. BMJ. 1999;318(7193):1276-79.

Kamath A. Prescribing generic drugs using a generic name: Are we teaching it right?. Ind J Med Ethics. 2016;1:194.

Bhattacharjee P, Das L, Ghosh R, Das UK, Chakraborty M. Knowledge, attitude and practice of generic medicines among doctors in a tertiary care teaching hospital of Tripura, India. Int J Basic Clin Pharmacol. 2017;6:1287-92.

Gupta R, Malhotra A, Malhotra P. A study on assessment of awareness in generic drugs among doctors in a tertiary care teaching hospital in north India. Int J Res Med Sci. 2018;6:1362-7.

Gawali UP, Gurung A, Deshkar AT, Sabat SK. Study of knowledge, attitude and practice of prescribing generic medicines by interns, residents and faculty in a tertiary care teaching hospital. Natl J Physiol Pharm Pharmacol. 2018;8(12)1631-34.

Joshi SS, Shetty YC, Karande S. Generic drugs -The Indian scenario. J Postgrad Med. 2019;65(2):67-9.




How to Cite

Kaur, S. (2020). Generic prescribing in India: a stumbling block. International Journal of Research in Medical Sciences, 8(9), 3426–3431.



Review Articles